Neurocrine Biosciences Stock Price (NASDAQ:NBIX)

Add to My Stocks
$44.05 $0.9 (2.09%) NBIX stock closing price Feb 17, 2017 (Closing)
Neurocrine Biosciences
17 FEB 2017
amigobulls logo
NBIX hand_up
NBIX vs S&P 500
Closing Price: Feb 17, 2017
$44.05 ( 2.09%)
S&P 500
2351.2 ( 0.17%)
52 Week Price Range
1 Year Return: 18.48%
Q3 Growth*
Profitable ?
net image
2016 Q3 Net Loss
Pays Dividend ?
12 Months Dividend
  : $0
Dividend Yield
  : -99900%
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Neurocrine Biosciences Snapshot Video

10 5 2

NBIX Stock Details

Prev Close* : $43.15
Market Cap:
Day Low: $42.48
52 Week Low: $32.18
Open: $42.9
Volume: 617977
Day High: $44.12
52 Week High: $55.15

Neurocrine Biosciences Stock Articles & Video

more news on NBIX stock

Neurocrine Biosciences News - From Partners

NBIX Stockcharts

View NBIX PE ratio, PS ratio stocks charts and compare with peers.
NBIX Chart
Note: Compare Neurocrine Biosciences stock price history with the index and industry peers.

Neurocrine Biosciences Financial Ratios

Receivables Turnover

NBIX Industry Peers

Company Price Change (%)
Patheon Nv (PTHN)31.40.28 (0.9%)
Stada Arzneimi (STDAF)61.21 (1.61%)
Abbvie (ABBV)61.770.29 (0.47%)
Repros Therapeutics (RPRX)1.220.03 (2.52%)
Auspex Pharma (ASPX)100.960 (0%)
Sage Therapeutics (SAGE)64.982.23 (3.55%)
Pfizer (PFE)33.620 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Esperion Therapeutics (ESPR)251.81 (7.81%)
Cempra (CEMP)3.350.18 (5.67%)
Portola Pharma (PTLA)31.681.41 (4.66%)
Tesaro Inc (TSRO)190.367.8 (4.27%)
Genocea Biosciences (GNCA)4.60.16 (3.6%)
Achaogen (AKAO)22.680.68 (3.09%)
ChemoCentryx (CCXI)7.040.21 (3.07%)
Top gainers from Medical-Drugs industry
* As of Feb 18, 2017
CompanyPriceChange (%)
ArQule (ARQL)1.20.27 (18.37%)
Infinity Pharma (INFI)2.440.13 (5.06%)
ImmunoGen (IMGN)2.430.07 (2.8%)
Lannett Co (LCI)22.40.6 (2.61%)
Zogenix (ZGNX)10.20.25 (2.39%)
La Jolla Pharma (LJPC)18.970.46 (2.37%)
Depomed (DEPO)16.470.38 (2.26%)
Top losers from Medical-Drugs industry
* As of Feb 18, 2017

Neurocrine Biosciences Financial Statements

income statement20152014201320122011
Net Sales Or Revenues19.76M-2.91M53.14M77.41M
Net Income-88.92M-60.54M-46.09M5.02M37.57M
Total Operating Expense113.97M64.4M52.58M51.68M43.49M
view Neurocrine Biosciences, Inc. income statement
balance sheet20152014201320122011
Total Assets474.78M243.03M154.67M195.97M138.36M
Total Liabilities50.33M34.33M34.26M41.6M78.28M
Shareholders Equity424.45M208.69M120.41M154.37M60.08M
view Neurocrine Biosciences, Inc. balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities8.7M1.6M12.23M-13.36M-4.08M
Net Cash From (Used By) Operating Activities-37.99M-47.14M-29.6M-35.29M-0.68M
Increase (Decrease) In Prop Plant And Equipment-1.92M-1.56M-0.5M-0.93M-0.5M
view Neurocrine Biosciences, Inc. cashflow statement

Neurocrine Biosciences, Inc. Stock News - Partner Headlines

Guru stock highlight   on Aug 31, 2015

Neurocrine Biosciences Stock Message Board

As of last trading day, Neurocrine Biosciences stock price was 44.05. Looking at Neurocrine Biosciences market capitalization, which currently stands at 3.76B, we can say that NBIX stock is a Mid cap stock. A value investor must look at the fundamentals of a stock, and perform Neurocrine Biosciences valuation, even though in the short-term sentiment and current breaking news might affect Neurocrine Biosciences stock price.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Neurocrine Biosciences is worth a lot, it will most likely be reflected in an inflated Neurocrine Biosciences stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 617977 shares were traded with a closing stock price of 44.05 as of 17 Feb, 2017, as can be seen from Neurocrine Biosciences stock quote. One can view Neurocrine Biosciences stock chart to follow the stock price trend. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Neurocrine Biosciences does not pay dividends. One can observe stock price trends and check for volatility by checking Neurocrine Biosciences stock price history.